GlassScriptPhysician profile
Tim P Lovell
NPI 1326030743
$1,808,498.59
in general payments reported to CMS, 2019-2025
5 companies · $111K in 2025
The $111K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217K · 2020: $349K · 2021: $278K · 2022: $394K · 2023: $217K · 2024: $243K · 2025: $111K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $409K · Travel and Lodging: $151K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $409,112.50 |
| Travel and Lodging | $151,322.42 |
| Food and Beverage | $10,581.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,808,149.98 | 2019-2025 | Mako, Accolade, Insignia |
| Tracpatch Health, INC | $250.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $64.06 | 2019 | |
| Avanos Medical | $22.33 | 2024 | On-Q* Pump and Accessories |
| Ferring Pharmaceuticals INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Lovell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.